K.D. Lissemore

Impact of hyperketonemia in early lactation dairy cows on health and production

Data from 1,010 lactating lactating, predominately component-fed Holstein cattle from 25 predominately tie-stall dairy farms in southwest Ontario were used to identify objective thresholds for defining hyperketonemia in lactating dairy cattle based on negative impacts on cow health, milk production, or both. Serum samples obtained during wk 1 and 2 postpartum and analyzed for beta-hydroxybutyrate (BHBA) concentrations that were used in analysis. Data were time-ordered so that the serum samples were obtained at least 1 d before the disease or milk recording events. Serum BHBA cutpoints were constructed at 200 micromol/L intervals between 600 and 2,000 micromol/L. Critical cutpoints for the health analysis were determined based on the threshold having the greatest sum of sensitivity and specificity for predicting the disease occurrence. For the production outcomes, models for first test day milk yield, milk fat, and milk protein percentage were constructed including covariates of parity, precalving body condition score, season of calving, test day linear score, and the random effect of herd. Each cutpoint was tested in these models to determine the threshold with the greatest impact and least risk of a type 1 error. Serum BHBA concentrations at or above 1,200 micromol/L in the first week following calving were associated with increased risks of subsequent displaced abomasum [odds ratio (OR) = 2.60] and metritis (OR = 3.35), whereas the critical threshold of BHBA in wk 2 postpartum on the risk of abomasal displacement was >or=1,800 micromol/L (OR = 6.22). The best threshold for predicting subsequent risk of clinical ketosis from serum obtained during wk 1 and wk 2 postpartum was 1,400 micromol/L of BHBA (OR = 4.25 and 5.98, respectively). There was no association between clinical mastitis and elevated serum BHBA in wk 1 or 2 postpartum, and there was no association between wk 2 BHBA and risk of metritis. Greater serum BHBA measured during the first and second week postcalving were associated with less milk yield, greater milk fat percentage, and less milk protein percentage on the first Dairy Herd Improvement test day of lactation. Impacts on first Dairy Herd Improvement test milk yield began at BHBA >or=1,200 micromol/L for wk 1 samples and >or=1,400 micromol/L for wk 2 samples. The greatest impact on yield occurred at 1,400 micromol/L (-1.88 kg/d) and 2,000 micromol/L (-3.3 kg/d) for sera from the first and second week postcalving, respectively. Hyperketonemia can be defined at 1,400 micromol/L of BHBA and in the first 2 wk postpartum increases disease risk and results in substantial loss of milk yield in early lactation.

The effect of meloxicam on behavior and pain sensitivity of dairy calves following cautery dehorning with a local anesthetic

Effects of a single injection of meloxicam on calf behavior, pain sensitivity, and feed and water intakes were examined following dehorning. Sixty Holstein heifer calves were blocked by age and randomly assigned to receive an i.m. injection of meloxicam (0.5 mg/kg) or a placebo. All calves were given a lidocaine cornual nerve block (5 mL per horn). Treatments and nerve blocks were administered 10 min before cautery dehorning. Continuous sampling of behavior was performed during five 1-h intervals using video recordings, and total daily activity was monitored using an accelerometer. A pain sensitivity test was administered with a pressure algometer, and feed and water intakes were recorded daily. Calves were sham-dehorned 24 h before actual dehorning to establish baseline values, and all variables were assessed at the same times following dehorning and sham dehorning for up to 48 h post-dehorning. Meloxicam-treated calves displayed less ear flicking during the 44 h following dehorning (increases of 4.29+/-1.10 and 1.31+/-0.66 ear flicks/h in the first 24 h, and increases of 3.27+/-0.89 and 0.55+/-0.50 ear flicks/h during the second 24 h, for control and meloxicam calves, respectively) and less head shaking during the first 9 h following dehorning (increase of 2.53+/-0.54 and 0.85+/-0.46 headshakes/h over baseline for control and meloxicam, respectively). Meloxicam-treated calves were less active than controls during the first 5 h following dehorning (activity 34.1+/-3.2 and 30.6+/-2.6 for control and meloxicam, respectively) and displayed less sensitivity to pressure algometry 4 h after dehorning (pressure tolerance of 1.62+/-0.13 kg of force and 2.13+/-0.15 kg of force for control and meloxicam calves, respectively). Changes in behavior suggest that meloxicam was effective for reducing post-surgical pain and distress associated with calf dehorning.

Factors associated with morbidity, mortality, and growth of dairy heifer calves up to 3 months of age

Calfhood disease is an important problem on many dairy operations that can have substantial effects on heifer survival and productivity, and has economic and welfare impacts. Neonatal calf diarrhea (NCD) and bovine respiratory disease (BRD) are the most common causes of morbidity and mortality in young dairy cattle. The objective of this observational study was to investigate factors associated with the risks of morbidity and mortality, and with growth, in commercial dairy heifers calves. A total of 2874 heifer calves from 19 commercial dairy farms in Minnesota and Ontario were enrolled at 1-7 days of age and followed for approximately 3 months. Using cut-points of serum total protein of 5.2 and 5.7 g/dl, the incidences of failure of transfer of passive immunity (FTPI) were 11 and 32%, respectively. A cut-point of 5.7 g/dl was the most predictive of BRD before 5 weeks of age (sensitivity=40%, specificity=69%). The positive predictive value was poor (PPV=18%), but the negative predictive value was good (NPV=87%). A cut-point of 5.2g/dl was most predictive of death before 5 weeks of age (sensitivity=27%, specificity=89%, PPV=5%, NPV=98%). Serum total protein during the first week of life was a poor predictor of NCD. Over 23% of calves were treated for diarrhea. Risk factors were weight at enrollment, other diseases before 2 weeks of age, and an interaction between season of birth and herd-level incidence of NCD. Almost 22% of calves were treated at least once for BRD. Factors associated with an increased risk of BRD included herd-level incidence of BRD, season of birth, navel dipping, other diseases before 2 weeks of age, failure of transfer of passive immunity, and manual control of temperature in pre-weaning housing. Administration of supplemental antibody products at birth was associated with a reduced incidence of BRD. Overall mortality was 3.5%. Risk of mortality was increased by treatment for BRD and other diseases. The mean average weight gain was 0.95 kg/day (range: 0.11-1.62 kg/day; SD=0.2). Twinning status, FTP, treatment for NCD or other diseases, and month of birth influenced body weight. This study illustrated relationships among various diseases, mortality, and growth. Furthermore, it demonstrated the importance of colostrum for protection against BRD and improved growth performance, while bringing into question the optimal method of determining failure of transfer of passive immunity.

Herd-and Cow-Level Prevalence of Foot Lesions in Ontario Dairy Cattle

The objectives of this cross-sectional study were to determine herd-level and cow-level prevalence estimates for 11 foot lesions in Ontario dairy cattle. Foot lesions were recorded by 5 hoof trimmers on 13,530 cows in 204 Ontario dairy herds from March 2004 to May 2005. Significant differences existed between free-stall and tie-stall housing. In free-stall housing systems, 46.4% of cows had a foot lesion, compared with 25.7% of cows in tie-stall barns. Digital dermatitis was the most common lesion in tie stalls, occurring in 9.3% of cows and 69.7% of the herds, whereas in free-stall herds, 22.7% of cows and 96.7% of the herds were affected. The most common hoof horn lesions were hemorrhages and ulcers, at 7.7 and 4.7% in tie-stall housing and 11.0 and 9.2% in free-stall housing, respectively. Foot blocks were used to treat 2.2% of cows in free stalls and 0.3% in tie stalls. Intraclass correlation coefficients ranged from 9.5 to 17.3 for hoof horn lesions and 28.0 to 38.7 for infectious lesions. In summary, foot lesions diagnosed at the time of hoof trimming are common in Ontario, and appropriate treatment for hoof horn lesions is low.

The impact of meloxicam on postsurgical stress associated with cautery dehorning

The objectives were to determine the duration of the stress response associated with cautery dehorning and to assess the effectiveness of the nonsteroidal anti-inflammatory drug meloxicam (Metacam, 20 mg/mL solution for injection) for reducing that response. Sixty Holstein heifer calves were blocked by age and randomly assigned to receive an i.m. injection of meloxicam or a placebo (0.5 mg/kg). All calves were given a lidocaine cornual nerve block delivered 5 mL per side 10 min before dehorning. To establish baseline values, calves were sham dehorned 24 h before actual dehorning. Blood samples were taken via indwelling jugular catheters at 0, 0.5, 1, 1.5, 2, 4, 6, and 24 h after the procedure. Heart and respiratory rates were also taken at these times. Data were analyzed using PROC MIXED in SAS. Analysis of covariance was employed to assess the difference between sham and dehorning at each time period. Dehorning was associated with elevated serum cortisol (d -1: 33.9 +/- 1.26; d 0: 46.2 +/- 2.33 nmol/L) and heart rate (d -1: 108 +/- 1.8; d 0: 109.4 +/- 2.4 beats per minute) in both groups for 24 h, and elevated respiratory rate (sham: 42.2 +/- 1.95 vs. dehorning: 45.1 +/- 2.19 respirations per minute) in both groups for 6 h. A treatment x time interaction was found for cortisol, with meloxicam calves having lower serum cortisol than controls until 6 h after dehorning (meloxicam: 49.7 +/- 4.37 vs. control: 63.0 +/- 6.94 nmol/L). There was no difference between the treatment groups at 24 h (meloxicam: 35.2 +/- 2.74 and control: 34.8 +/- 3.64 nmol/L of cortisol). Overall, the changes in heart rates (increase meloxicam: 3.74 +/- 0.96 vs. control: 4.70 +/- 1.87) and respiratory rates (increase meloxicam: 2 +/- 0.1 vs. control: 4 +/- 0.2) were greater in the control group compared with the meloxicam group. These results indicate that meloxicam reduced the physiological stress response to dehorning.

Factors influencing calf morbidity and mortality in smallholder dairy farms in Kiambu District of Kenya

Abstract Patterns of calf morbidity and mortality were examined for 78 of 90 randomly selected smallholder dairy farms in Kiambu District, Kenya that had at least one calf during the 12 months between July 1991 and June 1992. Overall, 201 calves (104 males and 97 females) were observed on at least one visit. The crude calf morbidity and mortality rates were 27% and 22% per year, respectively. Diarrhoea was the most common cause of morbidity and mortality. Factors associated with calf morbidity and mortality were studied via multiple logistic regression models stratified by the dairy society. The only risk factor associated with calf morbidity was calf age. Morbidity rates for calves from 1 and 3 months (4% per month) and greater than 5 months (3% per month) were higher than for calves less than 1 month or 4 and 5 months of age (both 1% per month). Increased calf mortality was associated with prior clinical illness (crude risk rate 8.2; P=0.000 ), lower red blood cell count ( P=0.006 ), and feeding of grain concentrate ( P=0.028 ). Feeding mineral was associated with lower mortality ( P=0.016 ).

Herd-level risk factors for seven different foot lesions in Ontario Holstein cattle housed in tie stalls or free stalls.

Worldwide, there is considerable between-herd variation within individual foot lesion prevalence studies. This variation suggests that herd-level risk factors are important from a prevention perspective. The objective was to determine the effect of selected risk factors on the prevalence of 7 foot lesions in both tie-stall and free-stall housing systems. As part of a cross-sectional foot lesion study 5 hoof trimmers recorded lesions for all cows that were foot trimmed in a herd. In addition, they completed a risk factor questionnaire for each herd. The impact of specific risk factors was evaluated using separate multi-variable models for both free-stall and tie-stall herds. The lesions evaluated were digital dermatitis, sole ulcer, sole hemorrhage, heel horn erosion, white line separations, white line abscess, and interdigital fibroma. Model types were selected based on herd-level lesion distribution. Detrimental risk factors identified in free-stall housing included increased alley scraping frequency (2.2- to 2.4-fold for sole ulcers) and trimming in summer or fall (-0.2-fold vs. spring and winter for digital dermatitis). Protective risk factors in free stalls included intermediate bedding depth (0.4-fold for 2.5 to 7.5 cm vs. more or less bedding for interdigital fibroma) and trimming heifers before calving (0.1-fold for white line abscess). In tie-stall herds no protective risk factors were identified. Detrimental risk factors for lesions in tie stalls included year-round access to outside areas (2.1-fold increase in digital dermatitis, 3.5-fold for white line separation, and 7.0-fold for interdigital fibroma vs. no or only seasonal exercise access), routine spraying of feet (2.0-fold increase in digital dermatitis), larger herds (3.0-fold increase in interdigital fibroma vs. <41 cow herds), and the use of wood bedding material (6.5-fold vs. straw bedding for interdigital fibroma). The risk factors identified need further evaluation to determine the temporal relationships, as well as whether the relationships with foot lesions are causal.

Factors influencing calf growth and daily weight gain on smallholder dairy farms in Kiambu District, Kenya

Abstract Dairy calf growth was studied on 90 randomly selected smallholder dairy farms in Kiambu District, Kenya between July 1991 and June 1992. The data were stratified by dairy society and farm in a two-stage random sampling protocol. Of the 90 farms, 78 had at least one calf during the study period. Overall, 201 calves (104 males and 97 females) were observed on at least one visit. Calf growth was estimated by daily weight gain. The overall median daily weight gain was 0.21 kg (ranging from −0.4 to 0.9 kg ). Approximately 14% of the monthly variability of daily weight gain was attributed to the farm. The remainder was associated with the variability between daily weight gains for the same calf from month to month. A multivariate regression method, Generalised Estimating Equations (GEE), was used to determine the association between daily weight gain and potential explanatory factors, since consecutive daily weight gains were correlated. Both farm- and calf-level factors were associated with calf daily weight gain. Lower daily weight gains were associated with increased number of years the owner was in dairy farming, lower amounts of milk fed to calves, male calves and the occurrence of clinical illness.

Associations between paratuberculosis milk ELISA result, milk production, and breed in Canadian dairy cows

The 3 objectives of this study were (1) to quantify milk production differences among cows with different paratuberculosis (ParaTB) milk ELISA results; (2) to determine if production differences existed in lactations preceding the test among cows with different ParaTB milk ELISA results; and (3) to assess whether Channel Island breeds were more likely to test positive with the ParaTB milk ELISA than other dairy breeds. Current and completed lactation records from 35,591 dairy cows in Ontario and western Canada that had been tested with a commercial ParaTB milk ELISA were included in the analysis. The first occurrence of the highest categorical test result was used to classify the cow. Cows were then grouped by the lactation in which the first high-positive (HTP), low-positive, or negative milk ELISA occurred, and comparisons were made within lactation groups. High test-positive cows were defined as those that had an optical density ≥ 1.0 on at least 1 ParaTB milk ELISA. The associations between ParaTB milk ELISA status and milk production, as measured by the 305-d milk yield, were assessed with a series of linear mixed models. The effect of breed on the likelihood of testing positive with the milk ELISA was assessed using a logistic mixed model for the lactation in which the first negative or positive ParaTB milk ELISA occurred. Test-positive cows produced on average 2.9 to 6.8% less milk than negative herdmates in the lactation in which they were tested. The HTP cows produced on average 466, 514, and 598 kg less milk than low-positive herdmates in lactations 1, 2, and 4, respectively. Cows testing low-positive in their second lactation had, on average, a 218-kg higher milk yield in their first lactation than their test-negative herdmates. Otherwise, no association was found between test result and milk production in preceding lactations. Differences in milk production among negative, test-positive, and HTP cows increased with increasing parity. Cows of the Channel Island breeds had 1.4 to 8.3 times the odds to test positive compared with other dairy breeds. The findings of this study are consistent with previous studies that have reported that milk production is lower in test-positive animals. The differences in milk production increased with increasing ELISA optical density scores and parity in which the animal tested positive. However, with the exception of second-lactation cows, no differences in milk production were observed in tests preceding lactations. The differences in milk ELISA status among dairy breeds support the need for further studies investigating the genetic component of ParaTB susceptibility.

The effects of viral vaccination of dairy heifer calves on the incidence of respiratory disease, mortality, and growth

Bovine respiratory disease (BRD) is one of the most common infectious causes of morbidity and mortality in young dairy cattle. The objective of this randomized clinical trial was to determine the effectiveness of 1 or 2 doses of a 5-way, modified-live viral vaccine, administered to heifer calves before weaning to aid in the prevention of BRD. The hypotheses were that vaccination would reduce the incidence of BRD and mortality, and that 2 doses would be more effective than 1. A total of 2,874 heifer calves from 19 commercial dairy farms in Minnesota and Ontario were enrolled at 1 to 7d of age and were followed until 3 mo of age. Calves were randomly assigned to receive a commercial, intramuscular, modified-live vaccine against bovine viral diarrhea virus types 1 and 2, bovine respiratory syncytial virus, bovine herpesvirus type 1, and parainfluenza virus type 3 at 15 to 21 d of age (2 wk only), 35 to 42 d (5 wk only), both 2 and 5 wk, or sterile saline at both times (unvaccinated controls). The incidence of failure of passive transfer was 11 or 32%, using cut-points of serum total protein of 5.2 and 5.7 g/dL, respectively. Overall, 22% of calves were treated at least once for BRD. The incidence risk of naturally occurring BRD was 7.7% before 2 wk of age, 8.0% between 2 and 5 wk, and 9.5% between 5 wk and 3 mo of age, and was not different between vaccination groups. Overall mortality throughout the 3-mo study period was 3.5%. Mortality was 1.6% before 2 wk of age, 0.5% between 2 and 5 wk, and 1.2% between 5 wk and 3 mo of age. The risk of mortality was not affected by vaccination. Mean average daily gain of 1.07 kg/d from 5 wk to 3 mo of age was not different between vaccine groups. In this population of commercial, home-raised calves, with an overall low incidence of failure of passive transfer, intramuscular vaccination with a multivalent, modified live viral vaccine at 2 or 5 wk of age or both was not associated with a decreased risk of BRD or mortality, or with growth until 3 mo of age. Reasons for these findings may include interference by maternal antibodies, unresponsiveness of the neonatal immune system, timing of immunity relative to pathogen exposure, disease caused by pathogens other than the viruses in the vaccine, or herd immunity. However, in populations with higher incidence of failure of passive transfer or risk of BRD, calves with low levels of specific antibodies may respond differently to vaccination.